• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠道与代谢综合征之间的关联呈剂量依赖性且受微生物相互作用影响:一项横断面研究。

Association Between Gut and Metabolic Syndrome is Dose-Dependent and Affected by Microbial Interactions: A Cross-Sectional Study.

作者信息

Zhou Qi, Pang Guofang, Zhang Zhirong, Yuan Huiping, Chen Chen, Zhang Nan, Yang Ze, Sun Liang

机构信息

The Key Laboratory of Geriatrics, Beijing Institute of Geriatrics, Beijing Hospital, National Center of Gerontology, National Health Commission, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, People's Republic of China.

Guangxi Jiangbin Hospital, Nanning, Guangxi, People's Republic of China.

出版信息

Diabetes Metab Syndr Obes. 2021 May 17;14:2177-2188. doi: 10.2147/DMSO.S311388. eCollection 2021.

DOI:10.2147/DMSO.S311388
PMID:34040404
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8139944/
Abstract

OBJECTIVE

is among the most abundant bacterial species in the human intestine; however, its relationship to metabolic syndrome (MetS)-which is linked to gut dysbiosis-is not known. In this study, we investigated the association between abundance and risk of MetS and its components, as well as dose-response effects and the influence of microbial interactions on the association.

METHODS

This cross-sectional study included 6896 Chinese participants aged 18 to 97 years from the Guangdong Gut Microbiome Project. MetS was defined according to Joint Committee for Developing Chinese Guidelines on Prevention and Treatment of Dyslipidemia in Adults criteria. The abundance of was assessed by 16S rRNA sequencing. Logistic regression analysis with adjustment for common confounders was performed to evaluate the association between and MetS and its components. Models with restricted cubic splines and interaction terms were used to examine the dose-response association and microbial interactions, respectively.

RESULTS

The prevalence of MetS was 20.4%, and the median abundance of was 0.08% (interquartile range: 0.04-0.93%). Increased abundance was associated with decreased risk of MetS ( <0.05), but this effect was not observed until the level was 0.2% of the total gut microbiota abundance (odds ratio=0.96, 95% confidence interval: 0.94-0.98). Of the 5 MetS components, obesity and hypertriglyceridemia showed the strongest association with , followed by reduced high-density lipoprotein cholesterol, hypertension, and hyperglycemia. Microbial interaction analyses showed that Ruminococcaceae and Lachnospiraceae were the predominant bacterial families and were not only correlated with abundance but also influenced the -MetS association.

CONCLUSION

There is a dose-response association between reduced risk of MetS and increased abundance of . The association between and 5 MetS components is variable and affected by microbial interactions.

摘要

目的

是人类肠道中最丰富的细菌物种之一;然而,其与代谢综合征(MetS)(与肠道生态失调相关)的关系尚不清楚。在本研究中,我们调查了其丰度与MetS及其组分风险之间的关联,以及剂量反应效应和微生物相互作用对该关联的影响。

方法

这项横断面研究纳入了来自广东肠道微生物组计划的6896名年龄在18至97岁之间的中国参与者。MetS根据《中国成人血脂异常防治指南联合委员会》标准定义。通过16S rRNA测序评估其丰度。进行了调整常见混杂因素的逻辑回归分析,以评估其与MetS及其组分之间的关联。分别使用具有受限立方样条和交互项的模型来检验剂量反应关联和微生物相互作用。

结果

MetS的患病率为20.4%,其丰度中位数为0.08%(四分位间距:0.04 - 0.93%)。其丰度增加与MetS风险降低相关(P<0.05),但直到其水平达到总肠道微生物群丰度的0.2%时才观察到这种效应(比值比 = 0.96,95%置信区间:0.94 - 0.98)。在5种MetS组分中,肥胖和高甘油三酯血症与它的关联最强,其次是高密度脂蛋白胆固醇降低、高血压和高血糖。微生物相互作用分析表明,瘤胃球菌科和毛螺菌科是主要的细菌科,不仅与它的丰度相关,还影响其与MetS的关联。

结论

MetS风险降低与它的丰度增加之间存在剂量反应关联。它与5种MetS组分之间的关联是可变的,并受微生物相互作用影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b268/8139944/3799aeebb789/DMSO-14-2177-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b268/8139944/589084b7efb2/DMSO-14-2177-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b268/8139944/dacd5fdeebc5/DMSO-14-2177-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b268/8139944/84c874296232/DMSO-14-2177-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b268/8139944/3799aeebb789/DMSO-14-2177-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b268/8139944/589084b7efb2/DMSO-14-2177-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b268/8139944/dacd5fdeebc5/DMSO-14-2177-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b268/8139944/84c874296232/DMSO-14-2177-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b268/8139944/3799aeebb789/DMSO-14-2177-g0004.jpg

相似文献

1
Association Between Gut and Metabolic Syndrome is Dose-Dependent and Affected by Microbial Interactions: A Cross-Sectional Study.肠道与代谢综合征之间的关联呈剂量依赖性且受微生物相互作用影响:一项横断面研究。
Diabetes Metab Syndr Obes. 2021 May 17;14:2177-2188. doi: 10.2147/DMSO.S311388. eCollection 2021.
2
Gut bacteria is associated with reduced risk of obesity: evidence from the American Gut Project.肠道细菌与肥胖风险降低有关:来自美国肠道计划的证据。
Nutr Metab (Lond). 2020 Oct 22;17:90. doi: 10.1186/s12986-020-00516-1. eCollection 2020.
3
Improvement of Lipoprotein Profile and Metabolic Endotoxemia by a Lifestyle Intervention That Modifies the Gut Microbiota in Subjects With Metabolic Syndrome.生活方式干预通过改变代谢综合征患者的肠道微生物群来改善脂蛋白谱和代谢内毒素血症。
J Am Heart Assoc. 2019 Sep 3;8(17):e012401. doi: 10.1161/JAHA.119.012401. Epub 2019 Aug 27.
4
A dysregulated bile acids pool is associated with metabolic syndrome and gut microbial dysbiosis in early adolescence.胆汁酸池失调与青少年早期的代谢综合征和肠道微生物失调有关。
Obesity (Silver Spring). 2023 Aug;31(8):2129-2138. doi: 10.1002/oby.23797. Epub 2023 Jul 4.
5
abundance is lower in severe obesity, but its increased level after bariatric surgery is not associated with metabolic health improvement.在严重肥胖症中,其含量较低,但减肥手术后其水平升高与代谢健康改善无关。
Am J Physiol Endocrinol Metab. 2019 Sep 1;317(3):E446-E459. doi: 10.1152/ajpendo.00140.2019. Epub 2019 Jul 2.
6
Regional distribution of and its associations with metabolic syndrome based on a population-level analysis.基于人群水平分析的[具体内容]区域分布及其与代谢综合征的关联。 (注:原文中“of”后面缺少具体内容)
PeerJ. 2020 Aug 4;8:e9591. doi: 10.7717/peerj.9591. eCollection 2020.
7
The effect of heritability and host genetics on the gut microbiota and metabolic syndrome.遗传和宿主遗传学对肠道微生物群和代谢综合征的影响。
Gut. 2017 Jun;66(6):1031-1038. doi: 10.1136/gutjnl-2015-311326. Epub 2016 Apr 6.
8
The Bacterium : A Sentinel for Gut Permeability and Its Relevance to HIV-Related Inflammation.细菌:肠道通透性的哨兵及其与 HIV 相关炎症的相关性。
Front Immunol. 2020 Apr 9;11:645. doi: 10.3389/fimmu.2020.00645. eCollection 2020.
9
Obesity, Akkermansia muciniphila, and Proton Pump Inhibitors: Is there a Link?肥胖、阿克曼氏菌黏液亚种和质子泵抑制剂:它们之间有联系吗?
Obes Res Clin Pract. 2020 Nov-Dec;14(6):524-530. doi: 10.1016/j.orcp.2020.10.006. Epub 2020 Nov 5.
10
Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology.黏蛋白阿克曼氏菌与肥胖人群饮食干预期间代谢健康的改善:与肠道微生物丰富度和生态的关系。
Gut. 2016 Mar;65(3):426-36. doi: 10.1136/gutjnl-2014-308778. Epub 2015 Jun 22.

引用本文的文献

1
Elucidating the gut microbiota-driven crosstalk: mechanistic interplay of lobetyolin in coordinating cholesterol homeostasis and anti-inflammatory pathways in hyperlipidemic mice models.阐明肠道微生物群驱动的串扰:在高脂血症小鼠模型中,洛贝林在协调胆固醇稳态和抗炎途径中的机制相互作用。
Front Microbiol. 2025 Aug 19;16:1625211. doi: 10.3389/fmicb.2025.1625211. eCollection 2025.
2
Distinct Microbial Signatures along the Female Reproductive Tract in Endometrial Cancer Patients.子宫内膜癌患者女性生殖道不同的微生物特征
J Microbiol Biotechnol. 2025 Aug 26;35:e2503048. doi: 10.4014/jmb.2503.03048.
3
The Role of Akkermansia muciniphila in Disease Regulation.

本文引用的文献

1
Gut bacteria is associated with reduced risk of obesity: evidence from the American Gut Project.肠道细菌与肥胖风险降低有关:来自美国肠道计划的证据。
Nutr Metab (Lond). 2020 Oct 22;17:90. doi: 10.1186/s12986-020-00516-1. eCollection 2020.
2
Gut microbiota in human metabolic health and disease.人体肠道微生物群与代谢健康和疾病。
Nat Rev Microbiol. 2021 Jan;19(1):55-71. doi: 10.1038/s41579-020-0433-9. Epub 2020 Sep 4.
3
Links between metabolic syndrome and the microbiome.代谢综合征与微生物群之间的联系。
嗜黏蛋白阿克曼氏菌在疾病调节中的作用。
Probiotics Antimicrob Proteins. 2025 Jul 9. doi: 10.1007/s12602-025-10642-y.
4
The effect of Akkermansia in patients with pregnancy induced hypertension.阿克曼氏菌对妊娠高血压患者的影响。
BMC Microbiol. 2025 Jul 2;25(1):386. doi: 10.1186/s12866-025-04087-0.
5
The Detrimental Impact of Ultra-Processed Foods on the Human Gut Microbiome and Gut Barrier.超加工食品对人体肠道微生物群和肠道屏障的有害影响。
Nutrients. 2025 Feb 28;17(5):859. doi: 10.3390/nu17050859.
6
Health Effects and Therapeutic Potential of the Gut Microbe .肠道微生物的健康影响与治疗潜力
Nutrients. 2025 Jan 31;17(3):562. doi: 10.3390/nu17030562.
7
Early life gut microbiome and its impact on childhood health and chronic conditions.早期生命阶段的肠道微生物群及其对儿童健康和慢性疾病的影响。
Gut Microbes. 2025 Dec;17(1):2463567. doi: 10.1080/19490976.2025.2463567. Epub 2025 Feb 7.
8
Examination of sex-specific interactions between gut microbiota and host metabolism after 12-week combined polyphenol supplementation in individuals with overweight or obesity.超重或肥胖个体补充多酚 12 周后,检测肠道微生物群和宿主代谢之间的性别特异性相互作用。
Gut Microbes. 2024 Jan-Dec;16(1):2392875. doi: 10.1080/19490976.2024.2392875. Epub 2024 Aug 25.
9
Soybean oil-based HFD induces gut dysbiosis that leads to steatosis, hepatic inflammation and insulin resistance in mice.基于大豆油的高脂饮食会诱发肠道菌群失调,进而导致小鼠出现脂肪变性、肝脏炎症和胰岛素抵抗。
Front Microbiol. 2024 Aug 6;15:1407258. doi: 10.3389/fmicb.2024.1407258. eCollection 2024.
10
The potential role of in liver health.在肝脏健康中的潜在作用。
Future Microbiol. 2024 Aug 12;19(12):1081-1096. doi: 10.2217/fmb-2023-0220. Epub 2024 Aug 7.
Evol Med Public Health. 2020 Feb 19;2020(1):45-46. doi: 10.1093/emph/eoaa007. eCollection 2020.
4
Function of in Obesity: Interactions With Lipid Metabolism, Immune Response and Gut Systems.肥胖中[具体物质]的功能:与脂质代谢、免疫反应和肠道系统的相互作用
Front Microbiol. 2020 Feb 21;11:219. doi: 10.3389/fmicb.2020.00219. eCollection 2020.
5
Cubic splines to model relationships between continuous variables and outcomes: a guide for clinicians.用于模拟连续变量与结果之间关系的三次样条曲线:临床医生指南
Bone Marrow Transplant. 2020 Apr;55(4):675-680. doi: 10.1038/s41409-019-0679-x. Epub 2019 Oct 1.
6
The gut microbiome and metabolic syndrome.肠道微生物组与代谢综合征。
J Clin Invest. 2019 Oct 1;129(10):4050-4057. doi: 10.1172/JCI129194.
7
Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study.在超重和肥胖的人类志愿者中补充 Akkermansia muciniphila:概念验证性探索性研究。
Nat Med. 2019 Jul;25(7):1096-1103. doi: 10.1038/s41591-019-0495-2. Epub 2019 Jul 1.
8
Understanding Competition and Cooperation within the Mammalian Gut Microbiome.理解哺乳动物肠道微生物组内的竞争与合作。
Curr Biol. 2019 Jun 3;29(11):R538-R544. doi: 10.1016/j.cub.2019.04.017.
9
Akkermansia muciniphila is a promising probiotic.黏蛋白阿克曼菌是一种有前景的益生菌。
Microb Biotechnol. 2019 Nov;12(6):1109-1125. doi: 10.1111/1751-7915.13410. Epub 2019 Apr 21.
10
Gut Microbiome in Obesity, Metabolic Syndrome, and Diabetes.肠道微生物组与肥胖、代谢综合征和糖尿病。
Curr Diab Rep. 2018 Oct 18;18(12):129. doi: 10.1007/s11892-018-1104-3.